PRESS RELEASE
6 February 2008
Eurofins Genetic Services gains ISO 9001:2000 Certification in the UK
Eurofins Genetic Services part of Eurofins Scientific, is pleased to announce the successful approval of its Quality management System to ISO 9001:2000 standard, as certified by Lloyd’s Register Quality Assurance (LRQA).
The revised ISO 9001 has a much greater focus on the management and measurement of business processes and their continuous improvement. John Rowley, Managing Director of Eurofins Genetic Services stresses the importance of this achievement as a demonstration of the company’s continued commitment to deliver the highest quality of service to all its customers.
Eurofins Genetic Services is a life sciences company specialising in the provision of Drug, Alcohol and DNA analytical testing services in the UK to a range of clients within the legal, public and private sectors.
This latest development continues the company objectives to provide it ’s customers with the highest levels of quality and safety whilst meeting the demands of regulatory authorities.
Notes for the editor:
Eurofins – a global leader in bio-analysis
With over 7,000 staff in more than 100 laboratories across 29 countries, Eurofins offers a portfolio of over 25,000 reliable analytical methods for evaluating the authenticity, origin, safety, identity, composition and purity of biological substances and products. The Group is committed to provide its customers with high quality services, accurate results in time and, if requested, expert advice by our highly qualified staff.
The Eurofins Group is one of the global market leaders in this field of applied life sciences. It intends to pursue its dynamic growth strategy and expand both its technology portfolio and its geographic reach. Through R&D, in-licensing and acquisitions, the Group draws on the latest developments in the field of biotechnology to offer its clients unique analytical solutions and the most comprehensive range of testing methods.
The shares of Eurofins Scientific are listed on the Euronext Paris (ISIN FR0000038259) and Frankfurt (WKN 910251) Stock Exchanges (Reuters EUFI.LN, Bloomberg ERF FP, ESF, EUFI.DE).
